J. Passweg

发表

Use of natural killer cells in hematopoetic stem cell transplantation

A. Tichelli, U. Koehl, M. Stern, 2005, Bone Marrow Transplantation.

Autologous hematopoietic stem cell transplantation for autoimmune diseases

J. Finke, J. Snowden, A. Gratwohl, 2005, Bone Marrow Transplantation.

Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia

J. Klein, A. Barrett, M. Horowitz, 1998, Bone Marrow Transplantation.

Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.

J. V. Stone, J. Klein, J. Wingard, 1999, The New England journal of medicine.

Myeloproliferative disorders: complications, survival and causes of death

A. Gratwohl, A. Tichelli, R. Skoda, 2000, Annals of Hematology.

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009

H. Einsele, G. Dini, A. Velardi, 2010, Bone Marrow Transplantation.

Increasing use of reduced intensity conditioning transplants: report of the 2001 EBMT activity survey

A. Gratwohl, H. Baldomero, Á. Urbano-Ispizua, 2002, Bone Marrow Transplantation.

Hematopoietic stem cell transplantation for autoimmune disorders.

A. Gratwohl, A. Tyndall, J. Passweg, 1999, Current opinion in hematology.

Impact of drug development on the use of stem cell transplantation: a report by the European Society for Blood and Marrow Transplantation (EBMT)

A. Gennery, N. Kröger, A. Nagler, 2017, Bone Marrow Transplantation.

Hematopoietic stem cell transplantation for hematological malignancies in Europe

N. Schmitz, A. Gratwohl, H. Baldomero, 2003, Leukemia.

C. Craddock, I. Yakoub-Agha, D. Blaise, 2014, Bone Marrow Transplantation.

Acquired Overlap Bone Marrow Failure Disorders

J. Passweg, 2017 .

Survival with bone marrow transplantation versus hydroxyurea or interferon for chronic myelogenous leukemia. The German CML Study Group.

H. Heimpel, J. Hasford, M. Horowitz, 1998, Blood.

Treatment of solid tumors following allogeneic bone marrow transplantation

R. Herrmann, S. Hofer, A. Gratwohl, 2000, Bone Marrow Transplantation.

Prevalence of untreated and uncontrolled cardiovascular risk factors in survivors of allogeneic cell transplantation

O. Pfister, T. Burkard, S. Gerull, 2020, Bone Marrow Transplantation.

Hematopoietic stem cell transplantation in Europe 1998.

A. Gratwohl, H. Baldomero, J. Hermans, 2000, The hematology journal : the official journal of the European Haematology Association.

Autologous haematopoietic stem cell transplants for autoimmune disease – feasibility and transplant-related mortality

N. Schmitz, K. Sullivan, P. Brooks, 1999, Bone Marrow Transplantation.

C-reactive protein and fever in neutropenic patients.

A. Gratwohl, M. Gregor, A. Tichelli, 2000, Scandinavian journal of infectious diseases.

Anemia: an indicator for malnutrition in the elderly

H. Stähelin, A. Gratwohl, A. Tichelli, 2001, Annals of Hematology.

Impact of high-resolution matching in allogeneic unrelated donor stem cell transplantation in Switzerland

A. Gratwohl, A. Tichelli, J. Tiercy, 2006, Bone Marrow Transplantation.

Blood and marrow transplantation activity in Europe 1997

A. Gratwohl, H. Baldomero, J. Hermans, 1999, Bone Marrow Transplantation.

Allogeneic bone marrow transplantation for CML: a report from the International Bone Marrow Transplant Registry.

M. Horowitz, P. Rowlings, J. Passweg, 1996, Bone marrow transplantation.

Repeated peripheral stem cell mobilization in healthy donors: time‐dependent changes in mobilization efficiency

A. Gratwohl, M. Gregor, J. Passweg, 1999, British journal of haematology.

Recent improvement in outcome of unrelated donor transplantation for aplastic anemia

A. Tichelli, P. Ljungman, J. Cornish, 2008, Bone Marrow Transplantation.

Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia

H. Schrezenmeier, G. Socié, E. Gluckman, 2006, Bone Marrow Transplantation.

Blood and marrow transplantation activity in Europe 1996

A. Gratwohl, H. Baldomero, J. Hermans, 1998, Bone Marrow Transplantation.

Mobilization of peripheral blood progenitor cells with vinorelbine and granulocyte colony-stimulating factor in multiple myeloma patients is reliable and cost effective

R. Herrmann, A. Gratwohl, A. Tichelli, 2003, Bone Marrow Transplantation.

Synergistic effect of sorafenib and cGvHD in patients with high-risk FLT3-ITD+AML allows long-term disease control after allogeneic transplantation

D. Heim, S. Gerull, M. Medinger, 2015, Annals of Hematology.

Cord blood banks collect units with different HLA alleles and haplotypes to volunteer donor banks: a comparative report from Swiss Blood stem cells

W. Holzgreve, V. Kindler, A. Gratwohl, 2009, Bone Marrow Transplantation.

Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation

A. Gratwohl, G. Stussi, J. Muntwyler, 2002, Bone Marrow Transplantation.

Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party

F. Locatelli, E. Lanino, A. Prete, 2005, Bone Marrow Transplantation.

‘Altered immunity syndrome’, a distinct entity in long-term bone marrow transplantation survivors?

A. Gratwohl, M. Gregor, A. Tichelli, 2001, Bone Marrow Transplantation.

Myeloid leukemia and myelodysplastic syndrome relapsing as granulocytic sarcoma (chloroma) after allogeneic bone marrow transplantation

A. Gratwohl, A. Tichelli, B. Speck, 1997, Annals of Hematology.

The influence of cyclosporin alone, or cyclosporin and methotrexate, on the incidence of mixed haematopoietic chimaerism following allogeneic sibling bone marrow transplantation for severe aplastic anaemia

F. Locatelli, F. Locatelli, H. Schrezenmeier, 2007, Bone Marrow Transplantation.

Effect of T cell subset dose on outcome of T cell-depleted bone marrow transplantation

M. Horowitz, N. Flomenberg, D. Margolis, 1997, Bone Marrow Transplantation.

Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation

A. Gratwohl, A. Tichelli, D. Heim, 2004, Leukemia.

Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the chronic leukemia working party of the EBMT

S. Iacobelli, J. Finke, P. Ljungman, 2010, Bone Marrow Transplantation.

Successful treatment of refractory acquired pure red cell aplasia (PRCA) by allogeneic bone marrow transplantation

A. Gratwohl, A. Tichelli, J. Passweg, 1999, Bone Marrow Transplantation.

Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation

A. Gennery, N. Kröger, J. Falkenburg, 2014, Bone Marrow Transplantation.

Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants

A. Gennery, N. Kröger, A. Nagler, 2015, Bone Marrow Transplantation.

Paternity wishes in long-term survivors after allogeneic hematopoietic SCT. A study of the late effects working party of the EBMT

M. Aljurf, A. Tichelli, G. Socié, 2013, Bone Marrow Transplantation.

Conditioning intensity in middle-aged patients with AML in first CR: no advantage for myeloablative regimens irrespective of the risk group–an observational analysis by the Acute Leukemia Working Party of the EBMT

C. Craddock, M. Labopin, P. Chevallier, 2015, Bone Marrow Transplantation.

T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities.

J. Klein, A. Barrett, A. Gratwohl, 2000, Blood.

Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemia

A. Gratwohl, P. Ljungman, K. Sobocinski, 1998, Bone Marrow Transplantation.

Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice

W. Wiktor-Jedrzejczak, N. Kröger, J. Finke, 2014, Bone Marrow Transplantation.

Bone marrow transplantation for severe aplastic anemia: has outcome improved?

J. Klein, M. Horowitz, R. Gale, 1997, Blood.

Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation

C. Hawkey, M. Labopin, J. Snowden, 2011, Bone Marrow Transplantation.

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe

N. Schmitz, H. Einsele, G. Dini, 2002, Bone Marrow Transplantation.

Repeated treatment with horse antilymphocyte globulin for severe aplastic anaemia

A. Gratwohl, A. Tichelli, B. Speck, 1998, British journal of haematology.

Hematopoietic stem cell transplantation activity in Europe 1999

A. Gratwohl, H. Baldomero, Á. Urbano-Ispizua, 2001, Bone Marrow Transplantation.

Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey

Y. Kodera, A. Gratwohl, H. Baldomero, 2016, Bone Marrow Transplantation.

Levels of anti-A/B antibodies after ABO-incompatible hematopoietic stem cell transplantation.

G. Stussi, U. Schanz, J. Passweg, 2005, Transplantation proceedings.

Increased stem cell dose, as obtained using currently available technology, may not be sufficient for engraftment of haploidentical stem cell transplants

A. Gratwohl, M. Gregor, A. Tichelli, 2000, Bone Marrow Transplantation.

Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually

A. Gennery, N. Kröger, A. Nagler, 2016, Bone Marrow Transplantation.

Hematopoietic SCT in Europe: data and trends in 2011

H. Bobby Gaspar, N. Kröger, J. Falkenburg, 2013, Bone Marrow Transplantation.

Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report

S. Montoto, A. Gennery, N. Kröger, 2017, Bone Marrow Transplantation.

Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation

N. Flomenberg, J. Casper, J. Passweg, 1997, Bone Marrow Transplantation.

Basic characteristics and safety of donation in related and unrelated haematopoietic progenitor cell donors – first 10 years of prospective donor follow-up of Swiss donors

J. Tiercy, B. M. Frey, Y. Chalandon, 2022, Bone Marrow Transplantation.

Haematopoietic stem cell transplantation for refractory autoimmune cytopenia

A. Wåhlin, P. Veys, A. Gratwohl, 2004 .

The EBMT activity survey: 1990–2010

A. Velardi, A. Gratwohl, H. Baldomero, 2012, Bone Marrow Transplantation.

Bone marrow transplantation--1994: a report from the International Bone Marrow Transplant Registry and the North American Autologous Bone Marrow Transplant Registry.

J. Armitage, M. Horowitz, R. Gale, 1994, Journal of hematotherapy.

The impact of T-cell depletion techniques on the outcome after haploidentical hematopoietic SCT

A. Gratwohl, A. Tichelli, M. Ansari, 2014, Bone Marrow Transplantation.

Order of application and liver toxicity in patients given BU and CY containing conditioning regimens for allogeneic hematopoietic SCT

A. Gratwohl, A. Buser, J. Passweg, 2011, Bone Marrow Transplantation.

Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice

W. Wiktor-Jedrzejczak, N. Kröger, J. Finke, 2014, Bone Marrow Transplantation.

Excellent outcome with a high proportion of mixed chimerism in patients with severe aplastic anemia treated with partially T-cell-depleted peripheral hematopoietic stem cell transplants

M. Ansari, Y. Chalandon, E. Levrat, 2016, Bone Marrow Transplantation.

M. Horowitz, P. Rowlings, J. Passweg, 1998, Hematology/oncology clinics of North America.

High stem cell dose will not compensate for T cell depletion in allogeneic non-myeloablative stem cell transplantation

A. Gratwohl, M. Gregor, A. Tichelli, 2002, Bone Marrow Transplantation.

Standard treatment of acquired SAA in adult patients 18–40 years old with an HLA-identical sibling donor

M. Aljurf, M. T. Lint, J. Passweg, 2013, Bone Marrow Transplantation.

Increased incidence of Hodgkin's disease after allogeneic bone marrow transplantation.

E. Jaffe, H. Deeg, M. Horowitz, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Graft-versus-myeloma after withdrawal of immunosuppression following allogeneic peripheral stem cell transplantation

A. Gratwohl, M. Gregor, A. Tichelli, 1999, Bone Marrow Transplantation.

Engraftment and Immune Reconstitution

A. Tichelli, G. Socié, A. Bacigalupo, 2002, Bone Marrow Transplantation.

Chemotherapy vs HLA-identical sibling bone marrow transplants for adults with acute lymphoblastic leukemia in first remission

M. Tanimoto, M. Tomonaga, R. Ohno, 1998, Bone Marrow Transplantation.

Autologous/syngeneic stem cell transplantation to treat refractory GvHD

J. Mehta, A. Gratwohl, J. Goldman, 2004, Bone Marrow Transplantation.

Report from the International Bone Marrow Transplant Registry and the Autologous Blood and Marrow Transplant Registry--North America.

J. Armitage, J. Klein, M. Horowitz, 1994, Clinical transplants.

Report from the International Bone Marrow Transplant Registry and Autologous Blood and Marrow Transplant Registry - North America.

J. Armitage, J. Klein, M. Horowitz, 1995, Clinical transplants.

Working Parties

M. Labopin, P. Chevallier, A. Nagler, 2015, Bone Marrow Transplantation.

Cardiac autonomic functioning is impaired among allogeneic hematopoietic stem cell transplantation survivors: a controlled study

J. Halter, J. Passweg, P. Grossman, 2017, Bone Marrow Transplantation.

Double allogeneic peripheral stem cell transplants for patients at high risk of relapse

A. Gratwohl, A. Tichelli, J. Passweg, 1998, Bone Marrow Transplantation.

Late relapse after stopping sorafenib in allogeneic hematopoietic stem cell transplant recipients

R. Mathew, S. Gerull, J. Halter, 2018, Bone Marrow Transplantation.

Challenges and opportunities for HSCT outcome registries: perspective from international HSCT registries experts

Y. Kodera, A. Gratwohl, M. Aljurf, 2014, Bone Marrow Transplantation.

Erratum: Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice (Bone Marrow Transplantatio (2014) 49 (319) DOI:10.1038/bmt.2013.210)

W. Wiktor-Jedrzejczak, N. Kröger, J. Finke, 2014 .

Myeloproliferative disorders: complications, survival and causes of death

A. Tichelli, R. Skoda, J. Passweg, 2000, Annals of Hematology.

The impact of T-cell depletion techniques on the outcome after haploidentical hematopoietic SCT

A. Gratwohl, R. Seger, Y. Chalandon, 2014, Bone Marrow Transplantation.

Effectiveness of immunosuppressive therapy in older patients with aplastic anemia. European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party.

A. Tichelli, P. Ljungman, M. Henry-Amar, 1999, Annals of internal medicine.